HeartBeam (BEAT) Stock Price, News & Analysis

Company Overview

HeartBeam, Inc. is a medical technology company developing portable and digital solutions for cardiac monitoring. Its proprietary technology is designed to capture, analyze and transmit electrocardiogram (ECG) data outside traditional clinical settings, with a focus on helping identify cardiac events such as atrial fibrillation and heart attacks.

The company’s flagship product is the HeartBeam AIMIGo system, which combines a compact, credit-card-sized ECG device with a smartphone application. The system is designed to record a three-dimensional, vector-based ECG and securely share the results with healthcare professionals for review. HeartBeam is also developing additional software and remote-monitoring applications intended to support earlier detection and management of cardiovascular conditions.

Founded in 2015 and headquartered in Santa Clara, California, HeartBeam primarily serves the U.S. digital health and cardiac-care markets. The company was co-founded by Branislav Vajdic, Ph.D., who serves as its president and chief executive officer. HeartBeam’s products are being developed to complement conventional cardiac testing and expand access to ECG monitoring in home and ambulatory settings.

Key Stats

• Today's Range: $0.41 to $0.42
• 50-Day Range: $0.36 to $0.65
• 52-Week Range: $0.36 to $4.00
• Volume: 348,340 shs
• Average Volume: 2.98 million shs
• Market Capitalization: $23.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Moderate Buy

HeartBeam Stock Analysis - MarketRank™

HeartBeam scored higher than 62% of companies evaluated by MarketBeat, and ranked 361st out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

HeartBeam has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 1 strong buy rating, 3 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

HeartBeam has a consensus price target of $4.00, representing about 861.5% upside from its current price of $0.42.

Amount of Analyst Coverage

HeartBeam has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for HeartBeam are expected to grow in the coming year, from ($0.37) to ($0.24) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of HeartBeam is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of HeartBeam is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

HeartBeam has a P/B Ratio of 6.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.91% of the float of HeartBeam has been sold short.

Short Interest Ratio / Days to Cover

HeartBeam has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in HeartBeam has recently decreased by 8.64%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

HeartBeam does not currently pay a dividend.

Dividend Growth

HeartBeam does not have a long track record of dividend growth.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: N/A

News Sentiment

HeartBeam has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for HeartBeam this week, compared to 3 articles on an average week.

Search Interest

Only 3 people have searched for BEAT on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, HeartBeam insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.95% of the stock of HeartBeam is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

7.77% of the stock of HeartBeam is held by institutions.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 11/11/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:BEAT
• CIK: 1779372
• Web: www.gobio.com
• Phone: 610-729-7000
• Fax: N/A
• Employees: 1,700
• Year Founded: N/A

Price Target and Rating

• Average Price Target for HeartBeam: $4.00
• High Price Target: $5.50
• Low Price Target: $2.00
• Potential Upside/Downside: +873.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.51)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$21.01 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -686.78%
• Return on Assets: -348.65%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.66
• Quick Ratio: 3.61

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.06 per share
• Price / Book: 6.85

Miscellaneous

• Outstanding Shares: 56,350,000
• Free Float: 46,234,000
• Market Cap: $23.16 million
• Optionable: Not Optionable
• Beta: -0.84